SAM
Silvercrest Asset Management’s Evolent Health EVH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.1M | Buy |
1,780,854
+51,429
| +3% | +$579K | 0.13% | 201 |
|
|
2025
Q1 | $16.4M | Buy |
1,729,425
+358,372
| +26% | +$3.39M | 0.12% | 212 |
|
|
2024
Q4 | $15.4M | Buy |
1,371,053
+372,793
| +37% | +$4.19M | 0.1% | 222 |
|
|
2024
Q3 | $28.2M | Buy |
998,260
+270,602
| +37% | +$7.65M | 0.19% | 159 |
|
|
2024
Q2 | $13.9M | Sell |
727,658
-6,828
| -0.9% | -$131K | 0.1% | 215 |
|
|
2024
Q1 | $24.1M | Sell |
734,486
-185,819
| -20% | -$6.09M | 0.16% | 164 |
|
|
2023
Q4 | $30.4M | Sell |
920,305
-89,762
| -9% | -$2.96M | 0.22% | 142 |
|
|
2023
Q3 | $27.5M | Buy |
1,010,067
+115,516
| +13% | +$3.15M | 0.21% | 143 |
|
|
2023
Q2 | $27.1M | Buy |
894,551
+59,596
| +7% | +$1.81M | 0.19% | 149 |
|
|
2023
Q1 | $27.1M | Buy |
834,955
+91,792
| +12% | +$2.98M | 0.21% | 141 |
|
|
2022
Q4 | $20.9M | Sell |
743,163
-78,731
| -10% | -$2.21M | 0.16% | 156 |
|
|
2022
Q3 | $29.5M | Sell |
821,894
-33,937
| -4% | -$1.22M | 0.24% | 129 |
|
|
2022
Q2 | $26.3M | Sell |
855,831
-11,254
| -1% | -$346K | 0.2% | 149 |
|
|
2022
Q1 | $28M | Sell |
867,085
-4,656
| -0.5% | -$150K | 0.18% | 154 |
|
|
2021
Q4 | $24.1M | Buy |
871,741
+1,045
| +0.1% | +$28.9K | 0.15% | 161 |
|
|
2021
Q3 | $27M | Sell |
870,696
-349,289
| -29% | -$10.8M | 0.18% | 152 |
|
|
2021
Q2 | $25.8M | Buy |
1,219,985
+64,454
| +6% | +$1.36M | 0.17% | 162 |
|
|
2021
Q1 | $23.3M | Sell |
1,155,531
-679,302
| -37% | -$13.7M | 0.16% | 169 |
|
|
2020
Q4 | $29.4M | Buy |
1,834,833
+93,263
| +5% | +$1.49M | 0.21% | 139 |
|
|
2020
Q3 | $21.6M | Sell |
1,741,570
-56,108
| -3% | -$696K | 0.19% | 144 |
|
|
2020
Q2 | $12.8M | Buy |
1,797,678
+227,401
| +14% | +$1.62M | 0.11% | 181 |
|
|
2020
Q1 | $8.53M | Sell |
1,570,277
-528,341
| -25% | -$2.87M | 0.09% | 211 |
|
|
2019
Q4 | $19M | Buy |
2,098,618
+58,033
| +3% | +$525K | 0.15% | 163 |
|
|
2019
Q3 | $14.7M | Buy |
+2,040,585
| New | +$14.7M | 0.12% | 181 |
|